Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Ischemic Stroke, Acute Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo Sponsors: Supergene, LLC Not yet recruiting Conditions: Ischemic Stroke, Acute Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo Sponsors:...

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Lipoprotein Disorder Interventions: Drug: Kylo-11 or matched placebo Sponsors: Kylonova (Xiamen) Biopharma co., LTD. Recruiting Conditions: Lipoprotein Disorder Interventions: Drug: Kylo-11 or matched placebo Sponsors: Kylonova (Xiamen) Biopharma co.,...

The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Sarcopenia in Elderly; Malnourished; Protein Supplementation; Muscle Mass; Physical Function; Strength Interventions: Other: MediDrink Platinum+; Other: MediDrink Platinum+ and PeptiStrong Sponsors: Nuritas Ltd; Medifood Hungary Innovation Kft...

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

by palligoelme@gmail.com | Jan 7, 2026 | Clinical Trials

​ Conditions: Bladder Cancer; Non-Muscle Invasive Bladder Cancer (NMIBC); Urothelial Carcinoma; Carcinoma in Situ (CIS); High-Grade Papillary Bladder Tumors; BCG-Unresponsive Bladder Cancer; Ta Stage Bladder Cancer; T1 Stage Bladder Cancer; BCG-Refractory Bladder...

Predicting DBS Outcomes in Dystonia Using Wearable Gait Sensors

by palligoelme@gmail.com | Jan 7, 2026 | Clinical Trials

​ Conditions: Dystonia Interventions: Device: Wearable Gait Sensor Analysis Sponsors: Ruijin Hospital; Suzhou Sceneray Medical Co. , Ltd; Beijing Pins Medical Co., Ltd; Medtronic Recruiting Conditions: Dystonia Interventions: Device: Wearable Gait Sensor Analysis...